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Introduction
Diabetes mellitus is possibly the world’s largest growing 
metabolic disorder. Global prevalence of diabetes has 
dramatically continued to increase. The difficulty of 
managing hyperglycemia in diabetes is the most important 
factor in reducing the risks associated with diabetes and its 
complications (Polonsky, 2012). Both fasting and postprandial 
glucose regulation are critical to achieve a long-term proper 
control in diabetic patients. The number of diabetic patients 
is rapidly increasing, and in consequence the control of their 
complications is a challenge. In this regard, medicinal plant 
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A B S T R A C T
The extraction of plant constituents is essential to isolate biologically active compounds, 
aimed to understand their role on the treatment of diabetes. This study was designed to explore 
the preliminary phytochemical and physicochemical analysis of Carica papaya L., Caricaceae, 
leaf, and further evaluation of its hypoglycemic effect on diabetic rats. C. papaya leaves were 
extracted using chloroform, n-hexane or ethanol. For each extract a phytochemical screening 
was performed. The tests were conducted in triplicate and the qualitative and quantitative 
determination of the various metabolites was done using analytical standards proposed by 
Mexican Herbal Pharmacopoeia. The chloroform extract, containing steroids and quinones 
as major components, was chosen to study C. papaya biological effects. The chloroform 
extract was evaporated to dryness, and doses 0, 31, 62, 125 mg/kg were orally administered 
in 300 μl polyethylene glycol to diabetic rats; and 0 and 62 mg/kg to non-diabetic rats. After 
a 20-day treatment with the chloroform extract, the animals were sacrificed and blood 
was obtained for biochemical studies. The main effect observed was a decrease in serum 
glucose, triglycerides and transaminases in diabetic rats after the administration of C. 
papaya chloroform extract. These results confirm the potential beneficial action of C. papaya 
to treat the symptoms of diabetic patients.
© 2014 Sociedade Brasileira de Farmacognosia. Published by Elsevier Editora Ltda. All rights reserved.
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extracts have an ancient background in this issue and modern 
medicine can gain valuable benefits from them. Phytochemicals 
and their derived products have been an extraordinary source 
of compounds with therapeutic and drug development 
potential (De D et al., 2012). These molecules are novel and 
complex structures that can be used in their original form, or 
can serve as lead molecules to develop derivatives with higher 
specificity and fewer side effects (Koehn and Carter, 2005). The 
World Health Organization has been particularly attentive to 
the potential offered by herbal medicine, the main subfield 
of traditional medicine practiced in different countries (WHO, 
2012). Ethnobotanical information indicates that more than 
800 plants are used as traditional remedies for the treatment 
of diabetes. Mexico has an extensive and diverse medicinal 
flora whose properties are part of the ancestral knowledge. 
Currently, natural compounds used as hypoglycemic agents 
have a strong impact on diabetic patients. 
Carica papaya L., is an herbaceous plant with prominent 
leaves (20-60 cm long), and is a member of the Caricaceae 
family, indigenous to the tropical region of Mexico, Central 
America and northern South America. C. papaya is distributed 
throughout the tropics and subtropics where it is extensively 
cultivated. The characterized metabolites from the plant are 
chitinase, glutaminyl cyclase and cysteine endopeptidases of 
class-II and III from Carica latex (Azarkan et al., 2006); linalool 
in fruit pulp, and alkaloids such as carpaine, pseudocarpaine, 
dehydrocarpaine I and II (Lim, 2012); and kaempferol and 
quercetin (Miean and Mohamed, 2001) in the leaves.
On the other hand, there are reports that describe the 
therapeutic effect of C. papaya leaf on dengue and malaria 
(Ahmad et al. 2011) and as anti-inflammatory (Owoyele et 
al., 2008). Other reports suggest that a fermented papaya 
preparation significantly reduces plasma glucose levels 
in healthy subjects and in patients with type 2 diabetes 
(Danese et al., 2006). The hypoglycemic activities of Carica 
papaya have been previously described for its fruit and leaves 
(Aruoma et al., 2010), nevertheless, the available information 
regarding the leaves is incomplete (Sasidharan et al., 2011). 
The present study was designed to perform phytochemical 
and physicochemical analyses of Carica papaya leaves, and to 
evaluate its hypoglycemic effect in diabetic rats.
Materials and methods
Plant material
Leaves from Carica papaya L., Caricaceae, were collected from 
June to September 2010 from Cintalapa, in the state of Chiapas, 
Mexico. The plant was authenticated at the Academic Division 
of Biological Sciences (DACB, acronym in Spanish) in the Juarez 
Autonomous University of Tabasco (UJAT, initials in Spanish) 
as Carica papaya. A voucher specimen was deposited in the 
herbarium (No. 32307) of this institution in Tabasco, Mexico.
Chemical products
Streptozotocin (STZ) was purchased from Sigma (St Louis, MO, 
USA). Insulin (Humulin* N) was obtained from Sanofi Aventis. 
All other chemicals of analytical grade were obtained from 
Merck. Kits for different enzyme assays were purchased from 
Biosystems S.A., Mexico.
Assays
Chemical analysis and quantitative assays of alkaloids, 
tannins, steroids, quinones and flavonoids content in C. papaya 
extract
Preliminary qualitative tests were carried out to determine 
the metabolites present in greater proportion in the leaf of C. 
papaya. Alkaloids, flavonoids, saponins, tannins, steroids and/
or terpenes (triterpenoids), and quinones were identified. A 
total of 30 g of dried and ground C. papaya leaves were placed 
in a 250 ml round-bottom flask, where they were macerated 
and extracted with hexane, chloroform and ethanol. All 
procedures were developed at room temperature. The 
extracts were used for the subsequent qualitative analysis 
of metabolites. Once the main secondary metabolites 
were determined, a quantitative assay was developed 
using spectroscopic techniques as described by Mexican 
Herbal Pharmacopoeia (FHEUM, 2001). Each assay on the 
hexanic, ethanolic and chloroform extracts was performed 
in triplicate; 10 g of dried and ground leaves of C. papaya 
were exhaustively extracted with the corresponding solvent 
employing a Soxhlet system. After the extraction the solvent 
was removed under vacuum. Steroids were quantified by 
the modified Lieberman-Burchard reaction (Robin, 1945) 
at an absorbance of 550 nm. A cholesterol standard curve 
(2-8 mm) was made to report the concentration of steroids 
(Barreto, 2005). The quantification of tannins was performed 
by the reaction with ferric citrate, and then absorbance was 
read at 525 nm. A tannic acid standard curve (0.1-0.5 mg/
ml) was prepared to report the concentration of tannins 
(ISO, 1988). Alkaloids were quantified by the reaction with 
bromocresol green read at 470 nm; a calibration curve with 
atropine (0.1-4 mg/ml) was constructed to report the alkaloid 
concentration (Fazel et al., 2008). For the quantification of 
quinones, the reaction with ferric chloride was employed and 
the absorbance was measured at 390 nm. A standard curve 
was prepared with a solution of 8-hydroxyquinone (0.010 
to 0.06 mg/ml) to evaluate the concentration of quinones 
(Pochapski et al., 2011).
Preparation of C. papaya leaf chloroform extract
The leaves of C. papaya were washed with tap water and 
cut into small slices. The slices were pulverized after being 
air-dryed. Dry samples (100 g) were placed in the Soxhlet 
system, where the extraction was conducted for 8 h with 500 
ml of chloroform. Afterwards, the solvent was evaporated 
under vacuum until the extract was completely dry, and was 
preserved at -20°C. The chloroform extract of C. papaya 
was used to a final concentration of 1 mg/ml.
Animals
Experiments were performed on adult male Wistar rats (body 
weight range: 250-300 g), 10 to 11 weeks of age. Animals were 
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housed and maintained at 22ºC under a 12:12 light/dark cycle, 
with free access to food and water. Experiments were carried 
out during the normal light/dark cycle and always started 
at the same hour (10 am). Efforts were made to minimize 
animal suffering and to reduce the number of animals used. 
All experiments complied with the Ethical Guidelines for the 
Use of Animals in Research; the study was approved by the 
local Internal Committee for the Care and Use of Laboratory 
Animals (003-10/CICUAL/DACS) of the Academic Division of 
Health Sciences (DACS, initials in Spanish), UJAT.
Induction of diabetes
Experimental diabetes (Courteix et al., 1994) was induced 
following an overnight fast by a single intraperitoneal 
injection of 60 mg/kg STZ (Sigma, St. Louis, MO, USA) freshly 
dissolved in distilled water. Control animals received 0.9% 
sterile saline. Hyperglycemia was confirmed four days after 
injection by measuring the tail vein blood glucose level with 
an Accu-Check Sensor Comfort glucometer (Roche, Mexico 
City). Only the animals with fasting blood glucose levels ≥ 
250 mg/dl were included in the study. No rat was rejected in 
this study lot.
Study design
In order to determine the hypoglycemic effect of C. papaya 
leaves in diabetic rats, oral doses of C. papaya chloroform extract 
(31, 62 and 125 mg/kg) were administered via oral in 300 μl of 
polyethylene glycol. In this study we chose C. papaya leaves 
due to their traditional use by diabetic patients in the region of 
Cintalapa, Chiapas, Mexico. These doses were selected based on 
a previous study employing different amounts of aqueous extract 
of C. papaya leaves (Juárez et al., 2012). Experimental non-diabetic 
rats also received similar doses of C. papaya leaf chloroform 
extract. Insulin-treated diabetic rats (5 U/kg insulin, i.p.) served 
as positive control (Gupta et al., 2004). For each group of eight 
rats, the necessary biochemical determinations were carried out 
to identify the pharmacological effects of C. papaya leaves. For all 
animal groups, the body weight was measured at baseline and 
every week after. Following the 20 days of treatment, 12 h after 
food withdrawal, rats were sacrificed by decapitation.
Chemical constituents
Extract (mean ± S.E.M; %)
Ethanol n-Hexane Chloroform
Alkaloids 
1.04 ± 10-4 ± 1.78 ± 10-6;
 (7.53 ± 10-4)
Steroids
5.98 ± 10-3 ± 2.20 ± 10-3;
 (0.231)
9.32 ± 10-3 ± 1.45 ± 10-4;
(0.360)
4.34 ± 10-2 ± 5.25 ± 10-3;
(1.678)
Quinones
2.20 ± 10-5 ± 5.81 ± 10-7;
 (1.53 ± 10-4)
1.27 ± 10-5 ± 4.80 ± 10-7;
(8.87 ± 10-5)
9.88 ± 10-6 ± 3.52 ± 10-7;
(6.87 ± 10-5)
Tannins 
4.85 ± 10-3 ± 1.76 ± 10-4;
 (0.824)
Data are expressed as molar (M) concentration ± SEM and as (percentage).
Table 1
Alkaloids, tannins, steroids, quinones and flavonoid content in C. papaya extracts.
Biochemical parameters
Blood was collected and serum was immediately frozen 
and stored at -70ºC until biochemical determinations 
were performed. The serum levels of glucose, cholesterol, 
triacylglycerides, high-density lipoprotein-cholesterol 
(HDL-C), aspartate aminotransferase (AST), and alanine 
aminotransferase (ALT) were analyzed using a Clinical 
Chemistry System from Random Access Diagnostics. 
Plasma insulin concentrations were determined by an 
enzymatic immunoassay method (Bertin-pharma rat insulin 
ELISA).
Statistical analysis
All data are expressed as mean ± S.E.M. One-way analysis of 
variance (ANOVA) was performed followed by Tukey’s test to 
compare the differences between treatments. Differences were 
considered statistically significant for p < 0.05.
Results
Chemical constituents of the extracts of C. papaya leaf.
Phytochemical analysis showed the presence of alkaloids 
and tannins in the ethanolic extract; and steroid and 
quinones in the three extracts. The amount of metabolites 
assayed is shown on Table 1. The highest concentrations 
of tannins (4.85 ± 10-3 ± 1.76 ± 10-4 M; 0.824%) and steroids 
(5.98 ± 10-3 ± 2.20 ± 10-3 M; 0.231%) were found in the ethanol 
extract of C. papaya leaf. Moreover, alkaloids (1.04 ± 10-4 ± 
1.78 ± 10-6 M; 7.53 ± 10-4%) and quinones (2.20 ± 10-5 ± 5.81 
± 10-7 M; 1.53 ± 10-4%) were also identified. The C. papaya 
hexane extract contained both steroids (9.32 ± 10-3 ± 1.45 
± 10-4 M; 0.360%) and quinones (1.27 ± 10-5 ± 4.80 ± 10-7 
M; 8.87 ± 10-5%); whereas in the chloroform extract, the 
steroid concentration was notable (4.34 ± 10-2 ± 5.25 ± 10-3 
M; 1.678%). As can be seen from the values, the chloroform 
extract showed the highest levels for both steroids and 
quinones. For this reason, such extract was used for the 
pharmacological tests.
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Effect of C. papaya leaf chloroform extract on body weight and 
blood glucose of STZ-induced diabetic rats
The STZ single-dose effect to induce type 1 diabetes in rats was 
confirmed by their significant weight loss and hyperglycemia 
as compared to non-diabetic animals (p < 0.05) (Fig. 1). The body 
weight was recorded every week; final data are shown in Fig. 1. 
There was a significant decrease in the area under the curve 
(AUC) of body weight of diabetic rats (3173 ± 120 g) compared 
with non-diabetic animals (3988 ± 110 g). The C. papaya 
chloroform extract (31 and 62 mg/kg) caused a minor reduction 
in body weight of diabetic rats (p < 0.05) than that displayed by 
control diabetic rats. In addition, this extract had a similar effect 
on the body weight AUC in diabetic rats receiving insulin (3639 ± 
98 g). An interesting fact is that oral administration of C. papaya 
chloroform extract (31, 62 mg/kg) induced significant decreases 
of the glucose AUC of diabetic rats (p < 0.05), similarly to that 
observed in the group receiving insulin; both cases compared 
with the diabetic control group (not showed). 
diabetic rats showed a significant elevation, in comparison to 
the values detected in non-diabetic control rats (88 ± 4.43 vs. 
75.67 ± 3.28 mg/dl) (Table 2). Serum triacylglycerol levels were 
also elevated in diabetic rats when compared to non-diabetic 
animals (180.5 ± 12.5 and 84.67 ± 10.17 mg/dl, respectively) 
(Table 2). A 20-day administration of C. papaya leaf extract to 
diabetic rats did not change serum cholesterol levels, whereas 
serum triacylglycerol (TAG) levels decreased significantly in C. 
papaya-treated rats compared with diabetic control animals (p 
< 0.05). High-density lipoprotein cholesterol (HDL-C) levels did 
not change with the administration of C. papaya leaf extract 
to diabetic rats in comparison to diabetic control and non-
diabetic control rats (Table 2). The insulin injection to STZ-
diabetic rats produced a significant decline in serum Chol, TAG 
and HDL-C (p < 0.05) compared with diabetic controls. 
The serum activities of AST and ALT, biomarkers of liver 
toxicity, were elevated in STZ-induced diabetic rats (395.8 ± 
28.3, 238.8 ± 22.5 U/l, respectively) when compared with non-
diabetic controls (249 ± 11.8, 56.3 ± 5.38 U/l, respectively) (Table 
2). The treatment of diabetic rats with 31 and 62 mg/kg of C. 
papaya leaf extract significantly reduced the activities of these 
biomarkers with respect to control diabetic rats (p < 0.05), but 
treatment with 125 mg/kg did not reduce the activity of these 
serum enzymes in diabetic rats (Table 2). Administration of 
insulin to diabetic rats showed a significant decrease (p < 0.05) 
in serum transaminases as compared to STZ-diabetic rats 
(Table 2). 
Determination of basal plasma insulin
The fasting plasma insulin levels were dramatically reduced 
in all groups of STZ-treated rats with or without C. papaya leaf 
extract (0.58 ± 0.09 ng/ml), when compared with non-diabetic 
control rats (1.06 ± 0.12 ng/ml) (p < 0.001) and diabetic rats 
treated with insulin (p < 0.001). Conversely, blood insulin levels 
were significantly increased in non-diabetic rats receiving 62 
mg/kg of C. papaya leaf extract (p < 0.05) (Table 2). 
Discussion
Currently, herbal products are being used as a source in 
medicine. The medicinal properties of plants have been part of 
ancient knowledge, and modern medicine benefits from them. 
In this sense, phytochemicals and their derivatives have been 
an extraordinary source of lead compounds for therapeutics 
and drug development.
Chemical constituents of the extracts of C. papaya leaf 
In reference to the phytochemical analysis of Carica papaya L., 
Caricaceae, leaf extract, the presence of flavonoids, tannins, 
alkaloids and organic acids in a methanolic extract has been 
previously documented (Khuzhaev and Aripova, 2000; Head 
et al., 1957). According to Canini (2007), the main compounds 
contained by C. papaya leaves are phenolic acids, as well as 
trace amounts of chlorogenic acid, compared to flavonoids and 
coumarin compounds. In their study, the authors suggested 
that the presence of such phenolic and coumarin compounds 
Figure 1 – Effects of Carica papaya leaf chloroform extract on 
the body weight of STZ-induced diabetic rats. Area under 
the curve of body weight obtained after a 20-day treatment 
with chloroform extract of C. papaya in diabetic rats. Results 
are presented as mean ± S.E.M.; number of rats per groups n 
= 8; p < 0.05, acompared to non-diabetic rats; bcompared to 
control diabetic rats. VEH, vehicle.
Biochemical parameters
Fasting blood glucose levels were highly elevated in diabetic 
animals (p < 0.05). After treatment with C. papaya chloroform 
extract (31-125 mg/kg), the fasting blood glucose level of 
diabetic rats was decreased compared with non-treated 
animals (Table 2). Administration of insulin to STZ-diabetic 
rats produced a significant reduction in fasting blood glucose 
level (p < 0.05) (Table 2). Serum cholesterol (Chol) levels in 
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in C. papaya leaves could partially explain the pharmacological 
properties of this plant. Different bioactive phytochemicals 
found in C. papaya possess a wide range of biological activities 
that can be of valuable therapeutic index. However, the 
absence or presence of metabolites may be due to differences 
in polarity of the solvents used for the extraction.
The results of the analysis of C. papaya leaves showed that 
ethanol extract contains a great proportion of steroids, quinones, 
tannins and alkaloids. There are reports that several drugs have 
been obtained from alkaloids-containin plants. This feature may 
be explained by the pharmacological effect of alkaloids, which 
at low doses have beneficial effects but at higher doses can be 
toxic (Li et al., 2011). Phytochemical screening of the extracts 
revealed the presence of different compounds. However, 
the pharmacological activities of C. papaya leaves cannot be 
determined solely by the result of the phytochemical analysis. 
Some of these phytocomponents are responsible for the 
hypoglycemic and hypolipemic effect in diabetic rats. Several 
studies report that these biological activities might be manifest 
due to the presence of flavonoids, alkaloids, steroids and 
quinones (Sanders et al., 2001; Ghosh et al., 2007). 
Effect of C. papaya leaf chloroform extract on biochemical 
parameters
In this study, we observed that the metabolites at greater 
concentration in the three extracts were steroids. It is known 
that steroids are molecules that regulate a variety of biological 
processes, and they possess a high potential, in drugs 
development, for the treatment of diseases. In addition, their 
pharmacological properties are diverse; they have analgesic, 
antipyretic, hypoglycemic, antidepressant, anti-inflammatory, 
antitumor and anti-rheumatoid properties (Fraile et al., 2012; 
Trevisan et al., 2012). The insulin deficiency in diabetes mellitus 
is known to stimulate lipolysis in the adipose tissue that gives 
rise to hyperlipidemia and fatty liver, and it is responsible for 
a decreased activity of the enzyme lipoprotein lipase, which 
hydrolyzes lipids, causing a significant increase in serum 
triacylglyceride concentration. Additionally to its hypoglycemic 
effect, C. papaya chloroform extract also caused a decrease 
in the concentration of serum triacylglycerides and total 
cholesterol in diabetic rats. HDL-C levels decreased in diabetes 
rats without treatment and even more in diabetic rats that 
received insulin. However, the treatment with different doses 
of C. papaya kept the HDL-C levels similar to those observed in 
control rats (Table 2). Interestingly, the mechanism by which 
this decrease in lipid concentration occurs could be explained 
by stimulation of lipolysis and higher fatty acid utilization. 
It has also been reported that long-term consumption of 
chronic D-glucosidase inhibitors improves lipid profiles in 
animal models of diabetes, suggesting that lower VLDL-
triacylglyceride secretion improves hypertriacylglyceridemia 
and hypercholesterolemia (Standl and Schnell, 2012).
Our study showed that both 31 and 62 mg/kg chloroform 
extract doses improved AST and ALT levels in diabetic rats, 
but the 125 mg/kg dose did not change aminotransferase 
concentrations. The administration of the plant extract to 
diabetic animals elicited a decrease in aminotransferases in 
serum (AST and ALT), a finding of clinical and toxicological 
importance given that changes in their activities are indicative 
of tissue damage by toxins or symptoms corresponding to 
hepatic disorders. This reduction of AST and ALT to their 
normal levels may be favored by the absence of alkanes in the 
extract. In this regard, it has been found that some parts of C. 
papaya contain large concentrations of alkaloids, which are 
highly toxic to humans and other animals (Akharaiyi, 2011).
The chloroform extract of C. papaya leaf reduced fasting 
blood glucose levels in STZ-treated rats (Kesari et al., 2005). 
Accordingly, recent research has been focused on isolation of 
steroids from plant sources; for instance, those often reported 
to exhibit anti-diabetic properties and have a relatively low 
toxicity (Afrose et al., 2009). In agreement with our results 
C. papaya 
mg/kg
Glucose 
(mg/dl)
Chol 
(mg/dl)
TAG 
(mg/dl)
HDL-C 
(mg/dl)
Ins 
(ng/ml)
AST 
(U/l)
ALT 
(U/l)
Diabetic
control 344.5 ± 95.5a 88.0 ± 4.4a 180.5 ± 12.5a 33.9 ± 2.3 0.58 ± 0.09a 395.8 ± 28.3a 238.8 ± 22.5a
INS 94.6 ± 1.2b 57.1 ± 10.5b 50.8 ± 1.7 b 25.0 ± 6.2b 1.54 ± 0.25b 266.4 ± 24.2b 165.7 ± 15.9b
31 122.2 ± 36.1b 83.2 ± 7.6 94.3 ± 18.9b 33.4 ± 2.7 0.38 ± 0.06a 160.6 ± 25.5b 119.3 ± 18.1b
62 113.8 ± 25.1b 87.3 ± 8.7 68.5 ± 15.0b 35.3 ± 2.7 0.32 ± 0.09a 166.8 ± 7.1b 116.8 ± 25.1b
125 268.4 ± 82.6 84.7 ± 10.5 99.0 ± 12.2b 34.2 ± 3.0 0.69 ± 0.17a 327.4 ± 16.3 153.8 ± 31.3
Non-diabetic
Control 70.4 ± 4.9 75.7 ± 3.3 84.7 ± 10.2 35.0 ± 0.6 1.06 ± 0.12 249.0 ± 11.8 56.3 ± 5.4
62 74.6 ± 12.4 64.5 ± 8.2 60.2 ± 3.8 33.4 ± 0.8 1.90 ± 0.26a 223.7 ± 19.3 71.7 ± 6.9
Data are expressed as mean  ±  S.E.M; n = 6. ANOVA followed by Tukey´s test (p < 0.05).  
aStatistically different from non-diabetic rats.  
bStatistically different from diabetic control rats.  
INS, insulin; Chol, cholesterol; TAG, triacylglycerol; HDL-Chol, high-density lipoprotein-cholesterol; Ins, Insulin; AST, aspartate aminotransferase; 
and ALT, alanine aminotransferase.
Table 2
Effects of C. papaya leaf chloroform extract on biochemical parameters of STZ-induced diabetic rats.
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regarding the hypoglycemic effect of C. papaya chloroform 
extract, we consider that steroids hamper the glucose 
absorption by inhibiting the hydrolyzing enzymes; which could 
consequently restrict postprandial glucose levels by delaying 
carbohydrate hydrolysis and intestinal absorption (Hamden et 
al., 2011; Standl and Shnell, 2012; Liu et al., 2013). It is known 
that diabetes causes structural and functional changes in 
intestinal glucose absorption, such as increase of glucose 
absorption that would cause postprandial hyperglycemia, a 
major risk factor for the diabetic patient (Hamden et al., 2011). 
Nevertheless, C. papaya chloroform extract had not effect 
on the fasting plasma insulin level of diabetic rats; this data 
suggests that C. papaya does not stimulate insulin secretion 
from the remnant E-cells. 
A study observed a higher hypoglycemic effect when 
glibenclamide-pregnenolone was administered to alloxan-
treated rats, than glibenclamide alone. This study suggested 
that a steroid nucleus is important for a high hypoglycemic 
effect of the glibenclamide-pregnenolone derivative, possibly 
conditioning the high degree of lipophilicity induced by it 
(Figueroa-Valverde et al., 2012).
The administration of the chloroform extract of C. papaya 
leaf significantly reversed the damage associated with STZ-
induced diabetes, revealing its hypoglycemic and hypolipidemic 
effects on diabetic rats. From the results obtained, it can be 
concluded that the hypoglycemic effect of C. papaya chloroform 
extract may be due to its phytoconstituents, especially 
steroids. The capability of the latter to slow glucose and 
lipid absorption in the digestive organs represents one of the 
therapeutic approaches used for the decrease of postprandial 
hyperglycemia. Taken together, the results suggest that the 
treatment with the chloroform extract of C. papaya could 
be beneficial in the treatment of hyperglycemia and related 
hyperlipidemia in diabetes. These results indicate that a 
delay in carbohydrate absorption improves the effectiveness 
of subcutaneous insulin. This controls postprandial 
hyperglycemia in patients with insulin-dependent diabetes 
mellitus, allowing a satisfactory postprandial glycemic control 
when insulin is administered immediately before ingestion. 
Thus, an agent such as Acarbose, which delays carbohydrate 
absorption (Azuma et al., 2006; Liu et al., 2013), may be useful 
as an adjunct to insulin in the treatment of diabetes mellitus.
In conclusion, this study suggests that the high concentrations 
of steroids in C. papaya leaves could be responsible for the 
hypoglycemic and hypolipidemic effect of the chloroform 
extract in diabetic rats. Nevertheless, more studies are required 
to identify, isolate, and study these molecules to characterize 
the observed pharmacologic activities of this plant. Our findings 
indicate that C. papaya leaf extract may be beneficial to diabetic 
patients and helpful in the prevention of diabetic complications 
by dyslipidemia improvement.
Authors’ contributions
JCDZ, IEJR and DYBO contributed the design and conducted the 
study, collection, analysis, interpreting of data and writing of 
the manuscript. DEAG (MS student) contributed in collecting 
plant sample and identification, and carrying out biochemistry 
analysis. LFRF and CELG performed qualitative and quantitative 
determination. LLM contributed in acquisition of funding and 
critically revising the manuscript. CATZ and JLBC performed 
statistical analyses and manuscript preparation. All authors 
read and approved the final manuscript. 
Conflicts of interest
The authors declare no conflicts of interest.
Acknowledgment
This study was financially supported by the Program for 
Research, Support and Consolidation of Academic Groups 
(PFICA, acronym in Spanish), UJAT-2010-C06-10 grant.
R E F E R E N C E S
Afrose, S., Hossain, M.S., Maki, T., Tsujii, H., 2009. Karaya root 
saponin exerts a hypocholesterolemic response in rats fed a 
high-cholesterol diet. Nutr. Res. 29, 350-354. 
Ahmad, N., Fazal, H., Ayaz, M., Abbasi, B.H., Mohammad, I., 
Fazal, L., 2011. Dengue fever treatment with Carica papaya 
leaves extracts. Asian Pac. J. Trop. Biomed. 1, 330-333.
Akharaiyi, F.C., 2011. Antibacterial, phytochemical and 
antioxidant activities of Datura metel. Int. J. Pharm. Tech. Res. 
3, 478-483. 
Aruoma, O.I., Hayashi, Y., Marotta, F., Mantello, P., Rachmilewitz, 
E., Montagnier, L., 2010. Applications and bioefficacy of the 
functional food supplement fermented papaya preparation. 
Toxicology 278, 6-16. 
Azarkan, M., Garcia-Pino, A., Dibiani, R., Wyns, L., Loris, R., 
Baeyens-Volant, D., 2006. Crystallization and preliminary 
X-ray analysis of a protease inhibitor from the latex of Carica 
papaya. Acta Crystallogr. Sect. F. Struct. Biol. Cryst. Commun. 
62, 1239-1242. 
Azuma, K., Toyofuku, Y., Iesaki, T., Otsuka, A., Tanaka, A., Mita, 
T., Hirose, T., Tanaka, Y., Daida, H., Kawamori, R., Watada, 
H., 2006. Acarbose, an alpha-glucosidase inhibitor, improves 
endothelial dysfunction in Goto-Kakizaki rats exhibiting 
repetitive blood glucose fluctuation. Biochem. Biophys. Res. 
Commun. 345, 688-693. 
Barreto, M.C., 2005. Lipid extraction and cholesterol 
quantification - a simple protocol. J. J. Chem. Educ. 82, 103. 
Canini, A., Alesiani, D., D’Arcangelo, G., Tagliatesta, P., 2007. Gas 
chromatography-mass spectrometry analysis of phenolic 
compounds from Carica papaya L. leaf. J. Food Compos. Anal. 
20, 584-590. 
Courteix, C., Bardin, M., Chantelauze, C., Lavarenne, J., Eschalier, 
A., 1994. Study of the sensitivity of the diabetes-induced pain 
model in rats to a range of analgesics. Pain 57, 153-160. 
Danese, C., Esposito, D., D’Alfonso, V., Cirene, M., Ambrosino, M., 
Colotto, M., 2006. Plasma glucose level decreases as collateral 
effect of fermented papaya preparation use. Clin. Ter. 157, 
195-198.
De D, Ali K.M., Chatterjee. K., Bera, T.K., Ghosh, D., 2012. 
Antihyperglycemic and antihyperlipidemic effects of 
n-hexane fraction from the hydro-methanolic extract of 
sepals of Salmalia malabarica in streptozotocin-induced 
diabetic rats. J. Complement. Integr. Med. 9, 1553-3840. 
 Isela E. Juárez-Rojop et al. / Rev Bras Farmacogn 24(2014): 341-347 347
Fazel, S., Hamidreza, M., Rouhollah, G., Mohammadreza, V., 2008. 
Sprectrophotometric determination of total alkaloids in some 
Iranian medicinal plants. Thai J. Pharm. Sci. 32, 17-20. 
FHEUM, 2001 Farmacopea Herbolaria de los Estados Unidos 
Mexicanos,. Secretaria de Salud. 10th ed. México. 
Figueroa-Valverde, L., Díaz-Cedillo, F., López-Ramos, M., García-
Cervera E, Pool-Gómez E, Cardena-Arredondo C, Ancona-
León G. 2012. Glibenclamide-pregnenolone derivative has 
greater hypoglycemic effects and biodistribution than 
glibenclamide-OH in alloxan-rats. Biomed. Pap. Med. Fac. 
Univ. Palacky Olomouc. Czech. Repub. 156, 122-127. 
Fraile, L., Crisci, E., Córdoba, L., Navarro, M.A., Osada, J., Montoya, 
M., 2012. Immunomodulatory properties of beta-sitosterol in 
pig immune responses. Int. Immunopharmacol. 13, 316-321.
Ghosh, D., Konishi, T., 2007. Anthocyanins and anthocyanin-rich 
extracts: role in diabetes and eye function. Asia Pac. J. Clin. 
Nutr. 16, 200-208. 
Gupta, S., Kataria, M., Gupta, P.K., Murganandan, S., Yashroy, 
R.C., 2004. Protective role of extracts of neem seeds in 
diabetes caused by streptozotocin in rats. J. Ethnopharmacol. 
90, 185-189.
Hamden, K., Jaouadi, B., Zaraî, N., Rebai, T., Carreau, S., Elfeki, A., 
2011. Inhibitory effects of estrogens on digestive enzymes, 
insulin deficiency, and pancreas toxicity in diabetic rats. J. 
Physiol. Biochem. 67, 121-128. 
Head, W.F. Jr, Lauter, W.M., 1957. Ultrasonic depolymerization of 
natural polymers. J. Am. Pharm. Assoc. Am. Pharm. Assoc. 
46, 617-621. 
ISO, 1988. Sorghum: Determination of Tannin Content. ISO 9648, 
International Organization for Standardization.
Juárez-Rojop, I., Díaz-Zagoya, J.C., Ble-Castillo, J.L., Miranda-
Osorio, P., Castell-Rodríguez, A.E., Tovilla-Zárate, C.A., 
Rodríguez-Hernández, A., Aguilar-Mariscal, H., Ramón-Frías, 
T., Bermúdez-Ocaña, D.Y., 2012. Hypoglycemic effect of 
Carica papaya leaves in streptozotocin-induced diabetic rats. 
BMC Comp. Alt. Med. 12, 236
Kesari, A.N., Gupta, R.K., Watal, G., 2005. Hypoglycemic effects 
of Murraya koenigii on normal and alloxan-diabetic rabbits. J. 
Ethnopharmacol. 97, 247-251. 
Khuzhaev, V.U., Aripova, S.F., 2000. Pseudocarpaine from Carica 
papaya. Chem. Nat. Comp. 36, 418-420.
Koehn, F.E., Carter, G.T., 2005. The evolving role of natural 
products in drug discovery. Nat. Rev. Drug Discov. 4, 206-220. 
Li, N., Xia, Q., Ruan, J., Fu, P.P., Lin, G., 2011. Hepatotoxicity 
and tumorigenicity induced by metabolic activation of 
pyrrolizidine alkaloids in herbs. Curr. Drug Metab. 12, 823-834. 
Lim, T.K., 2012. Carica papaya. In: Edible Medicinal and Non-
Medicinal Plants. Springer; 1:693-717.
Liu, S.Z., Deng, Y.X., Chen, B., Zhang, X.J., Shi, Q.Z., Qiu, X.M., 
2013. Antihyperglycemic effect of the traditional Chinese 
scutellaria-coptis herb couple and its main components in 
streptozotocin-induced diabetic rats. J. Ethnopharmacol. 145, 
490-498. 
Miean, K.H., Mohamed, S., 2001. Flavonoid (myricetin, quercetin, 
kaempferol, luteolin, and apigenin) content of edible tropical 
plants. J. Agric. Food Chem. 49, 3106-3112.
Owoyele, B.V., Adebukola, O.M., Funmilayo, A.A., Soladoye, A.O., 
2008. Anti-inflammatory activities of ethanolic extract of 
Carica papaya leaves. Inflammopharmacol. 16, 168-173. 
Pochapski, M.T., Fosquiera, E.C., Esmerino, L.A., Dos Santos, E.B., 
Farago, P.V., Santos, F.A., Groppo, F.C., 2011. Phytochemical 
screening, antioxidant, and antimicrobial activities of 
the crude leaves’ extract from Ipomoea batatas (L.) Lam. 
Pharmacogn. Mag. 7, 165-170.  
Polonsky, K.S., 2012. The past 200 years in diabetes. N. Engl. J. 
Med. 367, 1332-1340. 
Robin, E.D., 1945. The reaction of vitamin A with Lieberman-
Burchard reagent. Science 102, 17.
Sanders, R.A., Rauscher, F.M., Watkins, J.B., 2001. Effects of 
quercetin on antioxidant defense in streptozotocin-induced 
diabetic rats. J. Biochem. Mol. Toxicol. 15, 143-149. 
Sasidharan, S., Sumathi, V., Jegathambigai, N.R., Latha, L.Y., 
2011. Antihyperglycaemic effects of ethanol extracts of Carica 
papaya and Pandanus amaryfollius leaf in streptozotocin-
induced diabetic mice. Nat. Prod. Res. 20, 1982-1987. 
Standl, E., Schnell, O., 2012. Alpha-glucosidase inhibitors: 
cardiovascular considerations and trial evaluation. Diab. 
Vasc. Dis. Res. 9, 163-169. 
Trevisan, G., Rossato, M.F., Walker, C.I., Klafke, J.Z., Rosa, F., 
Oliveira, S.M., Tonello, R., Guerra, G.P., Boligon, A.A., Zanon, 
R.B., Athayde, M.L., Ferreira, J., 2012. Identification of the 
plant steroid D-spinasterol as a novel transient receptor 
potential vanilloid 1 antagonist with antinociceptive 
properties. J. Pharmacol. Exp. Ther. 343, 258-269. 
WHO, 2012. Traditional medicine strategy: 2002-2005. World Health 
Organization press, p. 1-6. 
